Product Code: ETC070124 | Publication Date: Jul 2023 | Updated Date: Jan 2024 | Product Type: Report | |
Publisher: 6Wresearch | No. of Pages: 70 | No. of Figures: 35 | No. of Tables: 5 | |
The orphan drugs market in Thailand has been steadily growing, driven by increasing awareness and advocacy for rare diseases and orphan conditions. Orphan drugs are pharmaceutical products developed to treat rare diseases that affect a small number of patients. In Thailand, the government and healthcare stakeholders have recognized the importance of addressing the unmet medical needs of patients with rare diseases, leading to favorable regulatory policies and incentives for orphan drug development. As a result, the market for orphan drugs has gained traction, offering new hope and treatment options to patients and their families.
Several drivers contribute to the growth of the orphan drugs market in Thailand. Firstly, the growing prevalence of rare diseases and the recognition of their impact on patients` quality of life have spurred the demand for effective treatments. Orphan drugs, specifically tailored for these conditions, offer new therapeutic possibilities. Secondly, government support, including expedited regulatory approval processes and incentives for orphan drug development, has encouraged pharmaceutical companies to invest in research and development. Additionally, advancements in biotechnology and precision medicine have facilitated the discovery and development of targeted therapies for rare diseases.
Despite its potential, the orphan drugs market in Thailand faces certain challenges. One significant challenge is the high cost of orphan drugs due to the limited patient population they serve. Ensuring affordability and accessibility of these drugs to patients is a concern for both healthcare providers and pharmaceutical companies. Additionally, the lack of awareness and expertise among healthcare professionals about rare diseases and their diagnosis can lead to delays in accurate diagnosis and treatment initiation. Educating healthcare providers and raising public awareness about rare diseases are essential steps to overcome this challenge.
The Covid-19 pandemic has had varying effects on the orphan drugs market in Thailand. While the immediate focus during the pandemic was on Covid-19 treatments and vaccines, the importance of ensuring continued access to orphan drugs for patients with rare diseases was highlighted. The pandemic also underscored the need for resilient supply chains to ensure a steady supply of essential medicines, including orphan drugs. Moreover, disruptions in healthcare services and patient care during lockdowns posed challenges to patients with rare diseases, necessitating innovative approaches, such as telemedicine, to ensure continuity of care.
The orphan drugs market in Thailand is supported by several key players, including multinational pharmaceutical companies and biotech firms. These players are actively involved in the development and commercialization of orphan drugs for rare diseases. Local pharmaceutical companies, such as Mega Lifesciences Public Company Limited, have also been engaged in providing orphan drugs and support services to patients with rare conditions in Thailand. Additionally, international organizations and patient advocacy groups play a crucial role in raising awareness, providing resources, and advocating for better access to orphan drugs and healthcare services for patients with rare diseases in Thailand. Collaborations between these key players and healthcare institutions contribute to advancing the orphan drugs market and improving patient outcomes in the country.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Thailand Orphan Drugs Market Overview |
3.1 Thailand Country Macro Economic Indicators |
3.2 Thailand Orphan Drugs Market Revenues & Volume, 2020 & 2027F |
3.3 Thailand Orphan Drugs Market - Industry Life Cycle |
3.4 Thailand Orphan Drugs Market - Porter's Five Forces |
3.5 Thailand Orphan Drugs Market Revenues & Volume Share, By Drugs, 2020 & 2027F |
3.6 Thailand Orphan Drugs Market Revenues & Volume Share, By Drug Type, 2020 & 2027F |
3.7 Thailand Orphan Drugs Market Revenues & Volume Share, By Therapy Class, 2020 & 2027F |
4 Thailand Orphan Drugs Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Thailand Orphan Drugs Market Trends |
6 Thailand Orphan Drugs Market, By Types |
6.1 Thailand Orphan Drugs Market, By Drugs |
6.1.1 Overview and Analysis |
6.1.2 Thailand Orphan Drugs Market Revenues & Volume, By Drugs, 2018 - 2027F |
6.1.3 Thailand Orphan Drugs Market Revenues & Volume, By Revlimid, 2018 - 2027F |
6.1.4 Thailand Orphan Drugs Market Revenues & Volume, By Rituxan, 2018 - 2027F |
6.1.5 Thailand Orphan Drugs Market Revenues & Volume, By Opdivo, 2018 - 2027F |
6.1.6 Thailand Orphan Drugs Market Revenues & Volume, By Keytruda, 2018 - 2027F |
6.1.7 Thailand Orphan Drugs Market Revenues & Volume, By Imbruvica, 2018 - 2027F |
6.1.8 Thailand Orphan Drugs Market Revenues & Volume, By Soliris, 2018 - 2027F |
6.2 Thailand Orphan Drugs Market, By Drug Type |
6.2.1 Overview and Analysis |
6.2.2 Thailand Orphan Drugs Market Revenues & Volume, By Biologics, 2018 - 2027F |
6.2.3 Thailand Orphan Drugs Market Revenues & Volume, By Non-Biologics, 2018 - 2027F |
6.3 Thailand Orphan Drugs Market, By Therapy Class |
6.3.1 Overview and Analysis |
6.3.2 Thailand Orphan Drugs Market Revenues & Volume, By Oncology, 2018 - 2027F |
6.3.3 Thailand Orphan Drugs Market Revenues & Volume, By Blood, 2018 - 2027F |
6.3.4 Thailand Orphan Drugs Market Revenues & Volume, By Endocrine, 2018 - 2027F |
6.3.5 Thailand Orphan Drugs Market Revenues & Volume, By Central Nervous Systems, 2018 - 2027F |
6.3.6 Thailand Orphan Drugs Market Revenues & Volume, By Cardiovascular, 2018 - 2027F |
6.3.7 Thailand Orphan Drugs Market Revenues & Volume, By Respiratory, 2018 - 2027F |
7 Thailand Orphan Drugs Market Import-Export Trade Statistics |
7.1 Thailand Orphan Drugs Market Export to Major Countries |
7.2 Thailand Orphan Drugs Market Imports from Major Countries |
8 Thailand Orphan Drugs Market Key Performance Indicators |
9 Thailand Orphan Drugs Market - Opportunity Assessment |
9.1 Thailand Orphan Drugs Market Opportunity Assessment, By Drugs, 2020 & 2027F |
9.2 Thailand Orphan Drugs Market Opportunity Assessment, By Drug Type, 2020 & 2027F |
9.3 Thailand Orphan Drugs Market Opportunity Assessment, By Therapy Class, 2020 & 2027F |
10 Thailand Orphan Drugs Market - Competitive Landscape |
10.1 Thailand Orphan Drugs Market Revenue Share, By Companies, 2020 |
10.2 Thailand Orphan Drugs Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |